Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1301.30
10.25
(0.79%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Laboratories launches novel molecule ‘Tegoprazan’ in India
>>
USFDA completes PAI at Dr. Reddy's biologics manufacturing facility in Hyderabad
>>
Dr. Reddy’s Laboratories informs about allotment of equity shares
>>
Dr. Reddy's Laboratories gains after getting EIR for API manufacturing facility in Telangana
>>
Dr. Reddy's Laboratories gets EIR for API manufacturing facility in Telangana
>>
Dr. Reddy's makes investment of Rs 565.40 crore in DRL Russia
>>
Dr Reddy's Laboratories moves higher on reporting marginal rise in Q1 consolidated net profit
>>
Dr Reddy's Laboratories reports marginal rise in Q1 consolidated net profit
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy's Lab - Quaterly Results
<<
<
4
5
6
...143
>
>>